Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
The Lancet（2018）
摘要
GlaxoSmithKline.
更多查看译文
关键词
cardiovascular outcomes,diabetes,cardiovascular disease,harmony outcomes,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要